You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TBPH Sale Disclosure
Farnum Rhonda · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$54.53K
Farnum Rhonda SVP, Comm & Medical Affairs
TBPH
Theravance Biopharma
TBPH
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
TBPH daily price context
Close on/before transaction
$16.32
Jun 15, 2026
First close after public filing
$16.58
Jun 18, 2026
30-day return after filing
+2.11%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 3,328 shares @ $16.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001898490-26-000010
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$218.17K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Theravance Biopharma, Inc. TBPH | Sale | Jun 15, 2026 | $54.56K |
| Theravance Biopharma, Inc. TBPH Current | Sale | Jun 15, 2026 | $54.53K |
| Theravance Biopharma, Inc. TBPH | Sale | Jun 15, 2026 | $109.08K |